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SUMMARY
Human pluripotent stem cells (hPSCs) are susceptible to numerical and structural chromosomal alterations during long-term culture.We
show thatmitotic errors occur frequently in hPSCs and that prometaphase arrest leads to very rapid apoptosis in undifferentiated but not
in differentiated cells. hPSCs express high levels of proapoptotic protein NOXA in undifferentiated state. Knocking out NOXAby CRISPR
or upregulation of the anti-apoptosis gene BCL-XL significantly reduced mitotic cell death, allowing the survival of aneuploid cells and
the formation of teratomas significantly larger than their wild-type parental hPSCs. These results indicate that the normally low
threshold of apoptosis in hPSCs can safeguard their genome integrity by clearing cells undergoing abnormal division. The amplification
of BCL2L1 on chromosome 20q11.21, a frequentmutation in hPSCs, althoughnot directly oncogenic, reduces the sensitivity of hPSCs to
damage caused by erroneous mitosis and increases the risk of gaining aneuploidy.
INTRODUCTION
For the safe use of human pluripotent stem cells (hPSCs) in
regenerative medicine, they should be devoid of mutations
that could render them or their differentiated progeny ma-
lignant upon transplantation into a patient (Goldring
et al., 2011). One important question is whether genetic
or epigenetic changes acquired during hPSC in vitro culture
will affect the safety and efficacy of derivatives of hPSCs
produced for therapeutic application (Andrews et al.,
2017). While at low passage, most of the hPSC lines have
normal diploid karyotype, the incidence of aneuploidy in-
creases significantly with passage number, and gains of the
whole or parts of chromosomes 1, 12, 17, and 20 are sub-
stantially more common than other changes (Amps et al.,
2011; Taapken et al., 2011). Most likely, these genetic
changes are selected because they confer a growth advan-
tage (Olariu et al., 2010), which may be attributed to their
ability to evade the bottlenecks that restrict the expansion
of wild-type cells in culture, including mass cell death
following plating, failure to re-enter the cell cycle, and
the high death rate of daughter cells in incipient colonies
(Barbaric et al., 2014).
The frequent appearance of hPSCs with gains of whole
chromosomes suggests their susceptibility to chromosome
segregation errors duringmitosis. In somatic cells a key reg-
ulatory mechanism controlling accurate chromosome
segregation is the mitotic checkpoint, which delays the
onset of anaphase and arrests cells in prometaphase to cor-
rect the defects (Stukenberg and Burke, 2015). After pro-
longed prometaphase arrest, cells may either die or exit
mitosis without proper chromosome separation, thereby
forming tetraploid or aneuploid cells in G1 phase, a process
termed mitotic slippage (Topham and Taylor, 2013). Cell
fates following mitotic slippage include apoptosis, senes-
cence, or re-entry into the cell cycle, with the latter often
resulting in highly aberrant genomes (Topham and Taylor,
2013). The frequency of aberrant divisions in hPSCs and
their behavior following the mitotic checkpoint activation
is poorly characterized. High rates of death in hPSC cul-
tures (Barbaric et al., 2014) suggest a reliance of cells
on apoptosis for clearing genetically damaged cells.
For example, hPSCs subjected to DNA-replication stress
in S phase rapidly commit to apoptosis rather than initiate
DNA repair mechanisms (Desmarais et al., 2012).
Given the important role of apoptosis in protecting the
genome stability of a cell population, an increase in
apoptotic threshold through overexpression of anti-
apoptotic genes could provide a mechanism for survival
of cells with genetic damage. This phenomenon, previ-
ously observed in cancer cells (Williams et al., 2005), may
be particularly pertinent to hPSCs. In a large-scale study
of karyotype and copy-number variation (CNV) in hPSCs
by the International Stem Cell Initiative (ISCI), 26% of
karyotypically normal hPSC lines examined contained am-
plifications of a small region of the long arm of chromo-
some 20 (20q11.21) including the BCL2L1 gene. Subse-
quent studies identified increased expression levels of
BCL-XL, the BCL2L1 anti-apoptotic isoform from the
amplified chromosome 20q11.21 region, as an underlying
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cause for the enhanced survival of the CNV cells (Avery
et al., 2013; Nguyen et al., 2014). However, it remains un-
known how acquired overexpression of BCL2L1may affect
the subsequent genetic stability of hPSCs.
Here we show that hPSCs commit to apoptosis rapidly in
response to nocodazole-induced prometaphase arrest or
following a highly aberrant cell division due to high mito-
chondrial priming. After differentiation, hPSCs are no
longer sensitive to prometaphase arrest. The proapoptotic
gene NOXA is responsible for the highly sensitive mito-
chondrial apoptosis present in hPSCs. Knockout of NOXA
byCRISPR in hPSCs or overexpression of the anti-apoptotic
protein, BCL-XL, significantly reduced cell death caused by
defective mitosis. BCL-XL overexpression or the presence
of the BCL2L1 CNV had enhanced survival ability, altered
mitochondrial morphology, and aneuploidy formation af-
ter perturbing mitosis. Our study reveals the vulnerability
of hPSC mitosis and comprehensively assesses the biolog-
ical consequence of gaining anti-apoptotic mutations in
hPSC. These findings reveal an important roadmap that
drives hPSC culture adaptation.
RESULTS
HPSCs Are Prone to Mitotic Division Errors
To analyze chromosomal dynamics during hPSC mitosis,
we performed time-lapse imaging of karyotypically normal
cells expressing histone H2B-mCherry (Figure 1A and
Video S1). In 73 cells analyzed by time-lapse microscopy,
the progression from chromosome condensation in pro-
phase to completion of cytokinesis lasted about 29 min
(Figures 1B and 1C), with prometaphase lasting 14.9 ±
4.5 min, metaphase 9.8 ± 8.1 min, and anaphase 4.3 ±
1.2 min (Figure 1C). Abnormal mitosis was observed in
over 30%of cells, and these included lagging chromosomes
(22%) and chromosomal bridges (8%) (Figures 1B–1E and
Video S2). Cell death during division could also be seen
(Figure 1B). We also examined fixed hPSCs and found
that cells inmitosis displayed similar errors as well asmulti-
polar division (Figure 1E).
Undifferentiated hPSCs Are Highly Sensitive to
Abnormal Mitosis-Induced Apoptosis, which Is
Independent of TP53
hPSCs have been reported to escape mitotic arrest due to
uncoupling of the mitotic checkpoint from apoptosis
(Mantel et al., 2007). However, they are highly sensitive
to apoptosis upon DNA damage (Liu et al., 2013). To test
whether hPSCs undergo apoptosis following perturbation
of mitosis, we exposed hPSCs to nocodazole (NOC), which
prevents the formation of the mitotic spindle. NOC treat-
ment for 18 h caused cell-cycle arrest in G2/M, as indicated
by the increase of 4N cells from 18% to 70% (Figure 2A).
Strikingly, 29% of cells were found to undergo apoptosis
with NOC treatment (Figure 2A). Similar results were ob-
tainedwith human induced pluripotent stem cells (hiPSCs)
(Figure S1A). In contrast to hPSCs, whenmouse embryonic
stem cells (mESCs) were treated with NOC, a significant
proportion of cells slipped through mitotic arrest without
division and formed tetraploid cells (8N) (Figure S1B), sug-
gesting that there are major differences in the control of
mitotic checkpoint between human and mouse PSCs.
We next examined the response of differentiated hPSCs
toward NOC treatment. All-trans retinoic acid (RA) was
used to induce differentiation (Figure 2B). After 1 day of
NOC treatment, only 43% cells were arrested in G2/M,
and less than 3% cells were apoptotic, much lower than
that in undifferentiated hPSCs (29%) (Figures 2C and
2D). To exclude the possibility of 4N cells slipping into
G1 phase, we monitored the human embryonic stem
cell (hESC) division following NOC treatment by time-
lapse imaging. As shown in Figure 2E, chromatin started
to condense from 15 min and remained as metaphase
chromosomes until 255 min. The arrested cells then
died at about 280 min without exit from mitosis (Fig-
ure 2E). In contrast to undifferentiated H9 cells, RA-
treated H9 cells stayed in metaphase arrest for about
480 min before entering apoptosis (Figure 2F). These re-
sults indicated that metaphase arrested hPSCs are much
quicker to enter mitotic death than differentiated cells.
We next investigated the role of mitochondrial integrity
and TP53 during mitotic arrest-induced cell death of
hPSCs. TMRE is a mitochondrial membrane potential
indicator that displays strong red fluorescence when
mitochondrial function is normal. Upon mitochondrial
damage, the membrane potential decreases and the red
fluorescence of TMRE diminishes accordingly. Fluores-
cence-activated cell sorting (FACS) results revealed that
about 31% of hPSCs showed reduced TMRE signal after
18 h of NOC treatment, which was consistent with their
apoptosis rate (Figures 2G and S1E). Western blot revealed
significant upregulation of cleaved caspase-3 (cCaspase-3)
and downregulation of anti-apoptotic protein BCL-XL
and MCL1 in undifferentiated hESCs, which confirmed
the initiation of apoptosis process (Figure 2H). In RA-
treated H9 cells, the expression of the anti-apoptotic pro-
tein MCL1 decreased but BCL-XL and BCL-2 proteins
increased markedly (Figure 2I), which may explain the
reduced apoptosis of these cells after NOC treatment. To
test whether mitotic death of hPSC is dependent on
TP53, we used short hairpin RNA (shRNA) to knock
down TP53 in H9 cells. Unexpectedly, TP53 knockdown
did not decrease NOC-induced hPSC death, but dramati-
cally alleviated cell death induced by etoposide, a DNA-
damaging drug by inhibiting topoisomerase (Figures 2J
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and 2L). Western blot confirmed that TP53 protein was
significantly reduced by shRNA (Figure 2K). Strikingly,
etoposide treatment, but not NOC treatment, induced
massive increase of TP53 protein in shNC cells (Figure 2K).
These results suggested that TP53 is involved in DNA
damage-induced apoptosis but not mitotic arrest-induced
apoptosis. In summary, the rapid cell death observed dur-
ing mitotic arrest was not caused by TP53 upregulation in
hPSC but was due to high mitochondrial priming.
We next tested whether hPSCs initiate apoptosis after
highly abnormal mitosis. Diploid human cells are known
to be unstable in the tetraploid state, although they often
form near-diploid aneuploid cells through multipolar
division (Ganem et al., 2007). H9 cells expressing H2B-
mCherry were treated with AZD1152, a specific inhibitor
of Aurora B kinase, which has been shown to cause chro-
mosome misalignment and cytokinesis failure (Sharif
et al., 2010). Time-lapse imaging analysis showed that
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Figure 1. Live-Imaging Study of hPSC
Mitosis
(A) Selective frames from time-lapse movies
of H2B-mCherry ESI-035 normal hPSC divi-
sion. The time (in minutes) is indicated at
the top of each frame.
(B) Bar graph representation of the length of
each phase of the mitosis based on live
imaging of 73 individual cells pooled
from three independent experiments. Prom-
etaphase, metaphase, and anaphase are
indicated by different colors, and different
types of division defects are marked by
indicated symbols.
(C) Mean duration (minutes) of prom-
etaphase, metaphase, and anaphase of ESI-
035-H2B-mCherry cells based on time-lapse
videos.
(D) Frequency of defective divisions in ESI-
035-H2B-mCherry cells based on time-lapse
videos.
(E) Abnormal mitosis in routine hPSC culture.
Lagging chromosome and multipolar division
are highlighted by yellow arrows (DNA in
blue, phosphorylated H3S10 in red, OCT4 in
green).
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AZD1152 (AZD)-treated hPSCs had severely misaligned
chromosomes during mitosis (Figure 3Bi). Many cells
had condensed chromosomes, indicating that they have
entered mitosis, but no discernible prometaphase, meta-
phase, or anaphase was observed (Figure 3C). Other cells
decondensed chromosomes without clear separation of sis-
ter chromatids, thusmaking anaphase and telophase indis-
tinguishable (Figure 3C). DNA content analysis showed
that by 24 h, a significant proportion of cells became tetra-
ploid (8N) (Figure 3D). After washing off AZD, the treated
cells underwent multipolar divisions with severely mis-
aligned chromosomes (Figure 3Bii) and their DNA content
decreased to near-diploid levels (2N and 4N) in 2 days (Fig-
ure 3D). Two days after AZD removal, 34% of cells entered
apoptosis and 30% cells had reduced TMRE fluorescence
(Figures 3E and 3F). Together, these results suggest that
following abnormal mitosis, hPSCs readily undergo
apoptosis due to high mitochondrial priming, and this
may be an important mechanism to eliminate stem cells
that may gain chromosome abnormalities.
NOXA Knockout or BCL-XL Overexpression
Significantly Reduced Apoptosis of Cells Undergoing
Erroneous Mitosis
NOXA is a BH3 domain-only proapoptotic protein highly
expressed in undifferentiated hPSCs and decreased dramat-
ically upon RA-induced differentiation (Figure 4A). To test
whether it is responsible for the rapid apoptosis of hPSC
during abnormal mitosis, we used CRISPR to knock out
NOXA gene in H9 cells. Four single guide RNAs (sgRNAs)
were designed against the first and second exons of
NOXA to ensure deletion of the coding region (Figure S2A).
We picked 24 clones, 7 of which had a deletion in NOXA
exons. Western blot confirmed the absence of NOXA pro-
tein in these clones (Figure 4B). We treated NOXA/
clones 2 and 4 with NOC and most cells became arrested
in G2/M phase (4N) (Figure 4C), but there were no more
than 10% of cells undergoing apoptosis in NOXA/ cells
compared with 33% in wild-type H9 cells (Figures 4D and
S2B). Thus, high levels of NOXA protein appeared to be
an important contributing factor to the low apoptosis
threshold in hPSCs.
Increased copy number of the chromosome 20q11.21 re-
gion can provide hPSCs with a survival advantage (Amps
et al., 2011; Avery et al., 2013), and the BCL2L1 gene prod-
uct BCL-XL had been shown to be responsible for the anti-
apoptotic effect of this amplicon (Avery et al., 2013). To test
whether BCL-XL increases the survival of hPSCs treated
with NOC, we generated doxycycline (Dox)-inducible
BCL-XL hPSCs (Figure S2C). The addition of Dox led to
the expression of hemagglutinin (HA)-tagged BCL-XL be-
ing detected by both immunostaining and western blot
(Figures 4E and 4F). Induced expression of BCL-XL mark-
edly reduced cell death caused by NOC treatment. The
apoptosis rate was 4% with Dox induction versus 14%
without Dox (Figures S2D and S2E). Dox-induced cells
Figure 2. NOC Treatment Caused Rapid Apoptosis in hPSCs
(A) H9 cells were treated with NOC, FACS analysis of cell-cycle profile, and apoptosis by Hoechst 33342 and Annexin V-PI staining. The
control was DMSO-treated cells (n > 3).
(B) Schematic timeline of the experiment/treatments.
(C) Cell-cycle profile and apoptosis rate of NOC-treated differentiated (RA+) H9 analyzed by Hoechst and Annexin V-PI staining and FACS
(n > 3 independent experiments).
(D) Bar graph presentation of apoptosis rate in NOC-treated H9 cells (A) and differentiated H9 cells (C) Average apoptotic cell percentages
are generated from three independent biological replicates (data presented as mean ± SEM; n.s., not significant; **p < 0.01, based on
unpaired Student’s t test).
(E) Images of H2B-mCherry cells treated with NOC; the time (in minutes) is indicated at the bottom of each frame. The arrow indicates a cell
that entered prometaphase at 15 min, arrested until 255 min, and died at 280 min.
(F) Dot plot of the prometaphase duration of NOC-treated H9 cells (n = 53) and differentiated (RA+) H9 (n = 31) before cell death. Each dot
represents one cell measured in the time-lapse video (data are presented as mean ± SEM; ****p < 0.0001, based on unpaired Student’s
t test, data pooled from three independent experiments).
(G) FACS analysis of mitochondrial membrane potential by TMRE dye staining during NOC treatment. The numbers represent the percentage
of cells with reduced TMRE fluorescence (n > 3 independent experiments).
(H) Western blot analysis of MCL1, BCL-XL, P-H3S10, cCaspase-3, and GAPDH protein levels (n = 3).
(I) Western blot of OCT4, BCL-XL, MCL1, BCL2, and GAPDH protein expression in undifferentiated (RA) and differentiated (RA+) hPSCs
(n > 3 independent experiments).
(J) FACS analysis of apoptosis in shNC and shTP53 H9 cells treated with NOC or etoposide by Annexin V-PI staining (n = 3 independent
experiments).
(K) Western blot showing knocking down of TP53 protein by shRNA. TP53 level was significantly upregulated by etoposide treatment but
not NOC treatment in shNC cells.
(L) Bar graph comparing the percentage of apoptotic cells in NOC- or etoposide-treated shNC and shTP53 H9 cells (data are presented as
mean ± SEM of three independent experiments; n.s., not significant; *p < 0.05, ***p < 0.001, based on unpaired Student’s t test).
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Figure 3. Abnormal Mitosis and Apoptosis Induced by Aurora Kinase B Inhibitor AZD1152
(A) Schematic timeline of the experiment.
(B) Images of H2B-mCherry H9 cells treated with AZD1152 (AZD) and after AZD wash-off. Arrows indicate severely misaligned
chromosomes.
(legend continued on next page)
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had significantly lower level of cCaspase 3 protein (Fig-
ure 4F), and maintained normal TMRE fluorescence inten-
sity (plusDox/minusDox = 31%:6%) (Figure 4G). Similarly,
BCL-XL overexpression also decreased the percentage of
apoptosis caused by AZD treatment from 21% to 10% (Fig-
ures 4I and 4J). These results suggest that BCL-XL can
reduce mitotic cell death by enhancing mitochondrial
resilience.
To obtain a comprehensive assessment of how NOXA
knockout or BCL-XL overexpression affect cells in normal
conditions and under mitotic stress, we also per-
formed global transcriptome profiling on five cell lines
including wild-type, BCL-XL overexpression (BCL-XL),
and NOXA/ H9 cells (Figure S4A). Principal component
analysis showed that the transcriptome of wild-type,
BCL-XL, and NOXA/ H9 cells were largely similar, but
became significantly different upon NOC treatment (Fig-
ure S4B). Compared with control cells, NOC-treated BCL-
XL and NOXA/ cells did not upregulate the NIK/NF-kB
or apoptosis pathway gene, suggesting that the activation
of these two pathways was inhibited by the anti-apoptotic
mutations (Figures S4C and S4D; Tables S1 and S2). A
similar trend was observed in iPSCs (Table S3). The pattern
of global gene expression correlated with the resilient
phenotype of BCL-XL and NOXA/ hESCs under mitotic
stress.
hPSCs with 20q11.21 CNV or BCL-XL Overexpression
Inhibit Cell Death followingMitotic Stress and Permit
Aneuploidy Formation
Since increased BCL-XL expression suppresses cell death
caused by NOC-induced prometaphase arrest, we studied
whether hPSCs with an amplification of chromosome
20q11.21 were also more resilient to cell death following
abnormal mitosis. ESI-CNV hPSC is a subline of ESI-035
hPSC with chromosome 20q11.21 CNV as the only muta-
tion (Avery et al., 2013). We filmed mitotic events in the
ESI-CNVcells that carry the20q11.21 amplicon (Figure 5A).
In these cells, prometaphase was 13.4 ± 4.3 min. The meta-
phase and anaphase durations were significantly shorter,
5.0 ± 3.1 min and 3.6 ± 3.7 min, respectively. The total
division time was shorter in ESI-CNV-H2B-mCherry cells
(22.0 ± 4.5 min) compared with that of the normal ESI-
035 cell line (29.0 ± 10.3 min). Besides, BCL-XL OE cells
also had shorter division time compared with wild-type
H9 (Figure 5D). Aberrant mitoses were also seen in ESI-
CNV cells (19%), compared with 33% in ESI-035 cells. We
did not see cell death after abnormal mitosis in ESI-CNV
cells (Figure 5A). Similar to inducible BCL-XL H9 cells,
ESI-CNV and BCL-XL overexpression cells both showed a
reduced rate of cell death after AZD treatment (Figure 5E).
The level of BCL-XL overexpression was comparable with
that in BCL2L1 CNV cells reported in other studies (Fig-
ure S5). Finally, as BCL-XL protected hPSCs from apoptosis
following highly abnormalmitosis, we next tested whether
it can help the survival of aneuploid cells. To this end, we
treated Dox-induced or non-induced BCL-XL H9 cells
with NOC or AZD for 18 h, by which time a significant pro-
portion of cells had arrested in the prometaphase of cell cy-
cle or had failed cytokinesis. The drugs were then washed
off and cells were allowed to resume cell-cycle progression.
After cells grew back, they were treated with NOC or AZD
for another 18 h. No wild-type H9 cells grew back after
repeated NOC or AZD treatment and release, whereas
BCL-XLOE cells survived (Figure 5F). Karyotype analysis re-
vealed that some AZD-treated and released BCL-XLOE cells
had gained chromosome abnormality, one with extra chro-
mosome 8 and 11 (Figure 5Fi–iv) and another one with tri-
somy 12 (data not shown). The aneuploidy rate increased
to 37% in AZD-treated BCL-XL OE cells compared with
that in control cells (Figure 5G). Even under normal condi-
tions, BCL-XL overexpression increased the aneuploid rate
from 6% to 12% on average, although this was not statisti-
cally significant (Figure 5G). Collectively, these results
demonstrated that a low threshold of apoptosis is impor-
tant to safeguard hPSCs from gaining chromosome abnor-
mality after highly aberrant mitosis.
Anti-apoptotic Mutations Enhance hPSC Survival and
Lead to Larger Teratoma Formation
To better understand how BCL-XL protects mitochondria,
we performed transmission electron microscopy (TEM)
onhPSCs.Mitochondria in BCL-XLOEH9 or ESI-CNV cells
had darker and more robust cristae compared with wild-
type and ESI-035 cells (Figure 6A), suggesting mitochon-
drial membrane remodeling may have contributed to the
enhanced survival of these cells. A number of genes that
potentially may enhance mitochondrial function were
also significantly upregulated in BCL-XL OE and NOXA/
H9 cells, such as APOO, TIMM10, NDUFB3, NDUFA9, MT-
ATP6 and 8, MT-ND1, and MT-CYB (Figure S6A). We next
tested the clonogenicity and tumorigenicity of hPSCs
(C) Quantitative analysis of the length of each phase of the mitosis in AZD-treated cells (n = 48) based on live imaging. The prometaphase,
metaphase, and anaphase are represented by different colors. Many cells condensed chromosomes but did not show distinguishable
mitotic phases, thus represented as ‘‘Exit mitosis.’’
(D–F) Flow-cytometric analysis of cell cycle (Hoechst 33342, D), apoptosis (Annexin V-PI staining, E), and mitochondrial membrane
potential (TMRE, F) at different time points after H9 cells were released from 24-h AZD treatment (error bars are shown as ±SEM of three
independent biological experiments; n.s., not significant; *p < 0.05, ***p < 0.001, based on unpaired Student’s t test).
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with increased levels of BCL-XL. Inducible BCL-XL cells
formed more colonies when plated as single cells at low
density after Dox addition. Similarly, more clones survived
after NOC or AZD treatment in Dox-induced cells (Figures
6B and 6C). We transplanted 1 3 106 cells to the groin po-
sition of immune-deficientmice. After 8 weeks, BCL-XLOE
H9 cells formed larger teratomas compared with wild-type
H9 cells. NOXA/ H9 cells also formed bigger teratomas,
although not as large as BCL-XL H9 cells (Figures 6D and
6E). To determine whether these teratomas contain undif-
ferentiated cells, we examined the expression level of
pluripotent genes OCT4. Teratomas from wild-type, BCL-
XL, and NOXA/ H9 also downregulated OCT4 mRNA
level, implying the absence of undifferentiated cells (Fig-
ure 6F). Histological analysis of the teratomas showed
that wild-type, BCL-XL, and NOXA/ H9 cells all had
well-differentiated ectoderm, mesoderm, and endoderm
tissues (Figure S6B). In addition, BCL-XL OE or NOXA/
cells all downregulated OCT4 and upregulated SOX17 and
FOXA2, similar to wild-type H9 cells during in vitro endo-
dermdifferentiation (Figures S6C and S6D). Together, these
results indicated that these anti-apoptotic mutations pro-
moted hPSC survival and teratoma growth but did not
affect their differentiation potential.
DISCUSSION
In this study we have shown that hPSCs exhibit a relatively
high frequency (30%) of division errors (measured through
time-lapse imaging), as evidenced by the presence of lag-
ging chromosomes, chromosome bridges, micronuclei,
and, to a lesser extent, multipolar divisions. As hPSCs can
self-renew indefinitely, the likelihood of gaining chromo-
somal abnormality increases substantially during long-
term in vitro culture. It has been reported that the mitotic
checkpoint is uncoupled from apoptosis in hPSCs (Mantel
et al., 2007). However, we found that hPSCs were not able
to slip into the next phase of the cell cycle during NOC
treatment. Instead, we found a rapid drop in their mito-
chondrial membrane potential and cell death within about
5 h post treatment, suggesting that the mitotic checkpoint
is functional in hPSCs and that the high mitochondrial
priming in undifferentiated hPSCs ensures rapid death of
cells experiencing mitotic stress. This is in stark contrast
to the response of somatic cells and mESCs. For example,
MCF7 human breast cancer cells and RPE1 cells start to
die or slip into interphase after about 10 h of prometaphase
arrest (Brito and Rieder, 2006; Orth et al., 2012; Uetake and
Sluder, 2010). Similarly, shortly after differentiation, hPSCs
could also withstand longer prometaphase arrest (close to
10 h) before slipping to anaphase or entering the next
cell cycle without division. Meanwhile, genome-damaged
cells would enter senescence and then die slowly like
many somatic cells (Bai et al., 2017; di Fagagna, 2008).
It was notable that NOC treatment did not induce signif-
icant TP53 upregulation in hPSCs, whereas the DNA
damage-inducing drug etoposide led to a substantial induc-
tion of TP53. Two groups reported that in hESCs, rapid
apoptosis occurred after DNA damage in a TP53-dependent
manner (Liu et al., 2013; Dumitru et al., 2012). In our ex-
periments, TP53 knockdown did not protect cells from
NOC treatment-induced cell death but alleviated etopo-
side-induced cell death (Figures 2J–2L), suggesting that
different mechanisms underlie cell death induced by
abnormal mitosis and DNA damage, albeit both involve
mitochondria. AsNOC-induced apoptosis is TP53 indepen-
dent, cells with BCL2L1 amplification will have a survival
Figure 4. Knocking Out NOXA or BCL-XL Overexpression Suppressed Cell Death Caused by Abnormal Mitosis
(A) Western blot showing NOXA protein is enriched in undifferentiated H9 cells, H1 cells, and hiPSCs, and significantly decreased upon
RA-induced differentiation (+) (n = 3 independent experiments).
(B) Western blot showing that seven NOXA/ clones had no NOXA protein expression. GAPDH was used as the loading control.
(C) FACS analysis of cell-cycle profile by Hoechst 33342 staining of wild-type H9 and NOXA/ clones treated with NOC for 18 h
(n > 3 independent experiments).
(D) FACS analysis of apoptosis by Annexin V-PI staining of wild-type H9 and NOXA/ clones treated with NOC for 18 h (n > 3 independent
experiments).
(E) Immunostaining of HA-BCL-XL localization in H9 cells. HA-tag, green; DNA, blue.
(F) Western blot analysis of ectopic BCL-XL, phosphorylated H3S10 (P-H3S10), and cCaspase-3 protein level. The different treatment
combinations are indicated above the western blots (n = 3).
(G) Flow-cytometric analysis of mitochondrial membrane potential by TMRE dye staining. Note that TMRE intensity did not drop in BCL-XL
overexpression cells (+Dox) (n = 3 independent experiments).
(H) Timeline of the Dox-inducible BCL-XL expression and AZD treatment.
(I) Western blot analysis showing that Dox-induced BCL-XL overexpression and AZD abolished P-H3S10 (n = 3 independent experiments).
(J) Flow-cytometric analysis of apoptosis (Annexin V-PI staining) of Dox-induced and non-induced H9 cells treated with AZD (data are
presented as mean ± SEM of three independent experiments; n.s., not significant; **p < 0.01, ***p < 0.001, based on unpaired Student’s
t test).
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advantage in the event of abnormal mitosis. Indeed, we
found that the proportion of aneuploid cells increased
from 6% to 12% on average after BCL-XL overexpression
in hPSCs. Furthermore, BCL-XL OE cells exhibited 37%
aneuploid rate after AZD treatment, whereas no wild-type
cell survived repeated NOC or AZD treatment. In agree-
ment with this result, the ISCI study found that, among
five cell lines that gained the BCL2L1 CNVat early passage,
three had karyotypically abnormal cells in later culture
(Amps et al., 2011). Together, these data suggest that anti-
apoptotic mutations can render hPSCs insensitive to
mitotic stress and enable the retention of cells with chro-
mosomal abnormalities in culture.
The proapoptotic Bcl2 family member NOXA appears to
be a rate-limiting factor in mitotic death. It is induced by
G2/M arrest and can promote MCL1 degradation to accel-
erate apoptosis (Haschka et al., 2015). We found that
NOXA is highly expressed in hPSCs, but quickly downregu-
lated upon differentiation (Figure 4A). Furthermore, knock-
ing out NOXA in hPSCs led to significantly less cell death
duringNOC treatment (Figure 4D). Therefore, we speculate
that hPSCs may control NOXA expression to set a highly
A
B C D
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Figure 5. Altered Mitotic Kinetics, Mito-
chondrial Morphology, Cell Survival, and
Tumorigenicity of ESI-CNV hPSCs and
BCL-XL Overexpression Cells
(A) Quantitative analysis of the length of
each phase of the mitosis of ESI-CNV cells
(n = 73, data pooled from more than three
independent experiments) based on time-
lapsemovies. Prometaphase,metaphase, and
anaphase are represented by different colors,
and different types of division defects are
marked by indicated symbols as in Figure 1.
(B) Mean duration (minutes) of prom-
etaphase, metaphase, and anaphase of ESI-
CNV-H2B-mCherry cells.
(C) Frequency of defective divisions in ESI-
CNV-H2B-mCherry cells.
(D) Dot plot of the mitosis duration in wild-
type H9 (n = 23) and BCL-XL OE (n = 21)
cells. Each dot represents one cell measured
in the time-lapse video (data pooled from
three independent experiments). Data are
presented as mean ± SEM; **p < 0.01, based
on unpaired Student’s t test.
(E) ESI-035 control, CNV, and BCL-XL OE cell
lines were cultured for 24 h in the presence
of 100 nM AZD. The levels of apoptosis were
measured at 6, 12, and 24 h following
inhibitor exposure. Solid lines indicate
healthy cells (green), apoptotic cells (or-
ange), and necrotic cells (red). Control cells
displayed increased cell death following
24-h exposure when compared with CNV and
BCL-XL OE cells. Error bars represent SEM
from three biological replicates.
(F) Karyotype analysis of DMSO-, NOC-, and
AZD-treated BCL-XL OE cells. Red circle
highlights trisomy of chromosomes 8 and 11.
(G) Bar graph of aneuploid cell percentage
in DMSO-, NOC-, and AZD-treated BCL-XL OE
cells (values shown are mean ± SEM from
three independent experiments; n.s., not
significant; *p < 0.05, based on unpaired
Student’s t test).
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sensitive mitochondria-apoptosis threshold and rapidly
eliminate cells going through abnormal mitosis.
Our transcriptome profiling found that anti-apoptotic
mutations can also affect global gene expression, particu-
larly when cells are under stress. Upon NOC treatment,
wild-type H9 cells and iPSCs, but not BCL-XL OE and
NOXA/ cells, upregulated both apoptosis and NIK/
NF-kB pathway genes (Figures S4D–S4F). The NIK/NF-kB
pathway could be activated by cytoplasmic DNA gener-
ated from different sources, such as micronuclei formed
after chromosome mis-segregation or DNA damage
(Crasta et al., 2012; Harding et al., 2017; Mackenzie
et al., 2017), or mitochondria DNA leakage (Ichim et al.,
2015; West et al., 2015). This is in accordance with our re-
sults that the mitochondrial membrane potential was
much better maintained in cells with anti-apoptotic mu-
tations. Therefore, anti-apoptotic mutations may prevent
the activation of innate immune response and NIK/
NF-kB pathway gene expression by strengthening mito-
chondria membrane.
The structure of the mitochondria is very different in
pluripotent cells and differentiated cells. The inner cell
mass (ICM) cells of human preimplantation embryos
have been shown to have spherical mitochondria with
very few cristae (Sathananthan and Trounson, 2000).
Similar to ICM cells, hPSCs also have immature mitochon-
dria with round and cristae-poor morphology (Folmes
et al., 2012). Using TEM, we found that our wild-type
hPSCs had cristae-poor mitochondria as described by other
groups. In BCL2L1 CNV cells and BCL-XL OE cells,
A B
C
ED F
G
Figure 6. Altered Mitochondrial
Morphology, Cell Survival, and Tumorige-
nicity of ESI-CNV hPSCs and BCL-XL Over-
expression Cells
(A) Transmission electron microscopy
images of mitochondria in wild-type, BCL-
XL H9 cells, and ESI-035, ESI-CNV cells.
M, mitochondria. Scale bar, 500 nm.
(B) Drug treatment and colony survival
assay of Dox-inducible BCL-XL OE H9 cells.
Cells were seeded at 5,000 cells/cm2,
cultured for 7 days, and treated with
DMSO, NOC, or AZD for 18 h. Thereafter,
drugs were removed and cells were
cultured for another 3 days followed by
alkaline phosphatase assay (dark-blue
color). Significantly more colonies survived
in +Dox-induced groups (n = 3 indepen-
dent experiments).
(C) Bar graph representation of colony
number of wild-type and BCL-XL OE cells
treated with DMSO, NOC, or AZD for 18 h.
After drug treatment, cells were cultured
for 2 days and colonies were visualized
by alkaline phosphatase assay (dark-blue
color). Data are presented as mean ± SEM
of three independent experiments; n.s.,
not significant; ***p < 0.001, based on
unpaired Student’s t test.
(D) Images of teratomas from wild-type,
BCL-XL OE, and NOXA/ H9 cells.
(E) Weight of teratomas formed by wild-
type, BCL-XL OE, and NOXA knockout H9
cells (data pooled from n = 3 independent
experiments). Data are presented as mean ±
SEM; *p < 0.05, **p < 0.01, based on un-
paired Student’s t test).
(F) qRT-PCR analysis of pluripotent genes (OCT4) in teratomas from wild-type, BCL-XL OE, and NOXA/ H9 cells (data from n = 3 inde-
pendent experiments). Data are presented as mean ± SEM; ***p < 0.001, based on unpaired Student’s t test; n.s., not significant.
(G) Cartoon illustrating how anti-apoptotic mutations may render hPSCs insensitive to mitotic stress and permit aneuploidy cell formation.
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mitochondria had darker and thicker cristae (Figure 6A).
Anti-apoptotic members of Bcl2 family proteins have
been shown to enhance mitochondrial integrity in multi-
ple ways. For example, BCL-XL overexpression inhibits
Ca2+-mediated multiple conductance channel opening to
block mitochondrial membrane permeabilization (Tornero
et al., 2011). Several studies reported that BCL-XL may also
function as anti-oxidant with BCL-XL overexpression
significantly reducing the levels of reactive oxygen species
induced by GSK2578215A (Pfeiffer et al., 2017; Saez-Atien-
zar et al., 2016). These mechanisms may underlie the
changed morphology and enhanced resilience of mito-
chondria observed in our study.
Despite the suppression of apoptosis, BCL-XL overex-
pression or NOXA knockout alone did not appear to lead
to malignant transformation of hPSC. Transplanted undif-
ferentiated BCL-XL OE and NOXA/ cells formed fully
differentiated teratomas with well-defined borders that
no longer contained pluripotent cells, albeit with signifi-
cantly larger size (Figures 6D–6F). This suggests that
anti-apoptotic mutations by themselves are not directly
oncogenic but can help the survival of hPSCs and their
differentiated derivatives. However, as elevated BCL-XL
levels permitted cells with chromosomal abnormality to
evade death, we think that constitutive overexpression of
anti-apoptotic genes should be avoided if the differentiated
progeny cells are to be used for transplantation. In our
transcriptome study, we also identified several genes
commonly upregulated in BCL-XL OE, NOXA/, and
shTP53 cells (Figure S4I). Among these, Arrestin B1
(ARRB1) has been shown to positively regulate ERK1/2
and AKT signaling, while attenuating the NF-kB pathway,
and so could enhance cell survival (Wang et al., 2006;
Zhang et al., 2017). A number of long non-coding RNAs
also increased several-fold in BCL-XL OE, NOXA/, and
shTP53 cells. For example, LNC00458 (also aligned to
BC026300) has been shown to have NANOG binding sites
at its promoter and was only expressed in undifferentiated
hESCs (Ng et al., 2012). Its expression level was 3- to 5-fold
higher in BCL-XL OE, NOXA/, and shTP53 H9 cells
compared with wild-type H9, H1, and hiPSCs. Taken
together, genes identified in our study that were enriched
in hPSCs with reduced apoptosis potential may be used
as biomarkers to evaluate whether cells are predisposed to
culture adaptation.
Our results have revealed the unique characteristics
and regulatory mechanism of hPSC mitosis and apoptosis.
In summary (Figure 6G), hPSCs express high levels of
NOXA, which determines the high priming state of mito-
chondria. Although the error-prone mitosis in hPSCs can
lead to the formation of cells with chromosome aberra-
tions, they are quickly eliminated due to the low apoptosis
threshold. BCL-XL overexpression or NOXA downregula-
tion can desensitize cells to mitotic stress and enable aneu-
ploidy formation.
To ensure the safety of hPSCs, methods to identify
20q11.21 CNVat single-cell level in an hPSC culture at rela-
tively low cost are urgently needed. Sensitive and reliable
biomarkers, including surface markers and the expression
of certain coding or non-coding genes that have strong cor-
relation with 20q11.21 CNV, will also be very useful for
detection purposes.With the decrease in cost and increased
throughput of second-generation DNA-sequencing tech-
nology, it will be possible to use sequencing-based assays
to simultaneously analyze the transcriptome and the copy
number of single-cell or single-cell-derived small colonies.
As hPSCs are highly primed for apoptosis and the BCL2L1
locus is frequently amplified inhPSCs, theyprovide amodel
to dissect the mechanism driving this adaptive mutation.
Analyzing the changes in epigenetic modification and 3D
genome around BCL2L1 locus when hPSCs are under stress
may provide important clues and shed light on how to
better safeguard the genome integrity of stem cells.
EXPERIMENTAL PROCEDURES
The teratomaanalysiswas conducted in accordancewith theGuide
for theCare andUseofAnimals forResearchPurposes. Theprotocol
for the teratoma formation assay in severe combined immunodefi-
ciency mice was approved by Institutional Animal Care and Use
Committee and Internal Review Board of Tsinghua University.
hPSC Culture
The hPSC lines used in this study were ESC lines H9, H1 (WiCell
Institute, Madison, WI, USA), human iPSC (generated from CD34+
human cord blood cells), and ESI-035 and ESI-035-CNV (A-STAR,
Singapore) (Avery et al., 2013). The cells weremaintained on inacti-
vated mouse embryonic fibroblast (MEF) cells in culture medium
consisting of KO-DMEM (Invitrogen) supplemented with nones-
sential amino acids (NEAA) (Invitrogen), 0.1 mM 2-mercap-
toethanol (Sigma-Aldrich), 1 mM GlutaMAX (Invitrogen), 20%
Knock-Out Serum-Replacement (Invitrogen), and 4 ng/mL basic
fibroblast growth factor (Peprotech). Cells were cultured at 37C
in a humidified atmosphere of 5% CO2 in air. Cells were passaged
with 1 mg/mL collagenase IV (Invitrogen) and seeded onto a
25-cm2 flask on feeder cells (mitomycin C-inactivated MEFs) For
feeder-free culture, hPSCs were grown for more than three passages
in the absence of feeders in E8 or in mTeSR (STEMCELL Technolo-
gies) on Matrigel (BD Bioscience) (all cells were regularly checked
and confirmed free of mycoplasma contamination, and have
diploid karyotype).
Live-Imaging Experiments
Live-imaging experiments were performed on a Leica AF6000 in-
vertedmicroscopewith a 403 objective for H9-H2B-mCherry cells,
and a Nikon TiE inverted fluorescence microscope fitted with an
sCMOS camera using a 1003 oil objective lens for ESI-035-H2B-
mCherry and ESI-CNV-H2B-mCherry cells.
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Flow-Cytometry Analysis, Immunostaining, and
Western Blot
Cell-cycle profile, apoptosis, and mitochondrial membrane
potential were analyzed by Hoechst 33342 (Dojindo) staining,
Annexin V/Dead Cell Apoptosis Kit (Invitrogen), and TMRE (Invi-
trogen) staining, followed by flow-cytometric analysis on a BD
LSRFortessa FACS machine (BD Biosciences). The detailed immu-
nostaining and western blot procedure, and antibodies used in
this study can be found in Supplemental Information.
Inhibitor Treatment
Nocodazole (Sigma) and AZD1152 (Tocris) were used to perturb
mitosis in hPSC. H9, ESI-035, and ESI-CNV cells were treated
50 ng/mL NOC or 100 nM AZD1152 for appropriate durations as
specified in each experiment. Etoposide was used to induce DNA
damage in hPSC. H9 cells were treated with 20 nM etoposide
(TargetMol) for 5 h.
Generation of H2B-mCherry, BCL-XL Overexpression,
TP53 Knockdown, and NOXA Knockout Cell Lines
H2B-mCherry ESI-035, H2B-mCherry ESI-035-CNV, and Dox-
inducible BCL-XL overexpression H9 lines were generated
by transfection with pCAG-H2B-mCherry-IRES-puro plasmid,
piggyBac plasmids with TRE3G promoter driving BCL-XL, and
CAG promoter driving TetON-3G transactivator, respectively.
TP53 knockdown H9 cells were constructed by infecting cells
with shTP53 expressing lentivirus. NOXA knockout H9 cells
were generated by Cas9 and sgRNA targeting TP53 gene. The
detailed procedure is described in Supplemental Information.
Clonogenicity and Karyotype Analysis
Dox-inducible BCL-XL H9 cells were seeded at 5,000 cells/cm2 and
cultured for 7 days. Dox was added from day 0 onward. Cells were
then treated with DMSO, NOC, or AZD for 18 h on day 4. After
drugs wash-off, cells were cultured in hESC medium with or
without Dox for 3 days. To quantify the number of surviving col-
onies, we fixed cells in 2% paraformaldehyde for 2 min, and re-
vealed alkaline phosphatase activity by a mixture of NBT and
BCIP (Roche) staining. For detection of aneuploidy cells, drug-
paused cells were cultured until confluent and sent for karyotyping
at the Reproductive Medicine Center of the Peking University
Third Hospital.
Transmission Electron Microscopy
For TEM study, H9 or ESI-035 cells were prefixed for 1 h at room
temperature in 1.25% glutaraldehyde in hESC medium followed
by fixation in 2.5% glutaraldehyde overnight at 4C. Sample
embedding and sectioning was performed by the TEM facility at
Tsinghua University and the University of Sheffield. The TEM im-
ages were acquired using a Hitachi H-7650 transmission electron
microscope at 80 KV.
Statistics
All error bars represent standard error of the mean (SEM) unless
otherwise indicated. An unpaired Student’s t test was used to deter-
mine significance of data unless otherwise indicated.
ACCESSION NUMBERS
The RNA high-throughput sequencing data are publicly
available at the National Center for Biotechnology Infor-
mation with Gene Expression Omnibus (GEO), accession
number GEO: GSE109786.
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